78MO Early safety assessment of durvalumab after sCRT in patients with stage III, unresectable NSCLC (PACIFIC-6)
| Autor: | Garassino, M.C., Mazieres, J., Reck, M., Delmonte, A., Bischoff, H.G., Bernabe, R., Perez, I. Diaz, Sawyer, W., Trunova, N., Faivre-Finn, C. |
|---|---|
| Zdroj: | In Journal of Thoracic Oncology April 2021 16(4) Supplement:S737-S737 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|